Aggressively attacking belly fat, with Cinch It(TM) promotions, BST is currently selling products which allow improvement of the Waist-to-Hips Ratio (WHR) associated with metabolic syndrome, an increased incidence of coronary heart disease. and type II Diabetes Mellitus by removing fat outside the abdomen with TCAL LVL. BST is also developing fourth generation twin cannula devices which will permit endoscopically guided, safe laparoscopic removal of the even more harmful visceral fat within the abdomen (Endoscopic Visceral Lipectomy or EVL) in a minimally invasive fashion and on January 20, 2012, BST received Notice of Allowance of U.S. Patent Application #12/462,596 filed 8/5/09 and titled “Endoscopically-guided tissue aspiration system for safely removing fat tissue from a patient.”
